Stay updated on Apitegromab in Later-Onset SMA Clinical Trial
Sign up to get notified when there's something new on the Apitegromab in Later-Onset SMA Clinical Trial page.

Latest updates to the Apitegromab in Later-Onset SMA Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has been updated to version 2.15.0 from version 2.14.4, indicating a revision in the content. The phrase 'Here’s how you know' has been modified, suggesting a change in the way information is presented.SummaryDifference1.0%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 7, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.7%
- Check59 days agoChange DetectedThe page has been updated to reflect a new completion status and a future date of March 7, 2025, while removing a previous status indicating that it was not actively recruiting and a date of May 13, 2024.SummaryDifference2%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
Stay in the know with updates to Apitegromab in Later-Onset SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apitegromab in Later-Onset SMA Clinical Trial page.